Guggenheim Capital’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-23,810
| Closed | -$375K | – | 1604 |
|
|
2025
Q4 | $375K | Buy |
+23,810
| New | +$425K | ﹤0.01% | 1422 |
|
|
2024
Q1 | – | Sell |
-4,751
| Closed | -$356K | – | 1873 |
|
|
2023
Q4 | $356K | Sell |
4,751
-1,833
| -28% | -$131K | ﹤0.01% | 1597 |
|
|
2023
Q3 | $561K | Sell |
6,584
-5,210
| -44% | -$494K | ﹤0.01% | 1361 |
|
|
2023
Q2 | $1.29M | Buy |
11,794
+3,334
| +39% | +$316K | 0.01% | 1045 |
|
|
2023
Q1 | $702K | Sell |
8,460
-6,919
| -45% | -$651K | 0.01% | 1343 |
|
|
2022
Q4 | $1.58M | Buy |
15,379
+1,310
| +9% | +$151K | 0.01% | 945 |
|
|
2022
Q3 | $1.49M | Sell |
14,069
-7,428
| -35% | -$814K | 0.01% | 965 |
|
|
2022
Q2 | $2.36M | Buy |
21,497
+4,030
| +23% | +$399K | 0.02% | 823 |
|
|
2022
Q1 | $1.82M | Buy |
17,467
+3,629
| +26% | +$377K | 0.01% | 1069 |
|
|
2021
Q4 | $1.69M | Buy |
13,838
+2,618
| +23% | +$291K | 0.01% | 1137 |
|
|
2021
Q3 | $1.29M | Sell |
11,220
-30
| -0.3% | -$3.18K | 0.01% | 1286 |
|
|
2021
Q2 | $1.09M | Buy |
11,250
+790
| +8% | +$68.6K | 0.01% | 1445 |
|
|
2021
Q1 | $771K | Buy |
10,460
+3,800
| +57% | +$282K | 0.01% | 1516 |
|
|
2020
Q4 | $454K | Sell |
6,660
-2,128
| -24% | -$139K | ﹤0.01% | 1680 |
|
|
2020
Q3 | $514K | Buy |
8,788
+2,914
| +50% | +$153K | ﹤0.01% | 1436 |
|
|
2020
Q2 | $266K | Sell |
5,874
-133
| -2% | -$6.36K | ﹤0.01% | 1652 |
|
|
2020
Q1 | $347K | Sell |
6,007
-703
| -10% | -$48.1K | ﹤0.01% | 1491 |
|
|
2019
Q4 | $418K | Sell |
6,710
-998
| -13% | -$59K | ﹤0.01% | 1662 |
|
|
2019
Q3 | $444K | Sell |
7,708
-1,144
| -13% | -$63.3K | ﹤0.01% | 1671 |
|
|
2019
Q2 | $480K | Buy |
8,852
+6
| +0.1% | +$304 | ﹤0.01% | 1673 |
|
|
2019
Q1 | $417K | Buy |
8,846
+1,552
| +21% | +$86K | ﹤0.01% | 1774 |
|
|
2018
Q4 | $413K | Sell |
7,294
-23,923
| -77% | -$1.34M | ﹤0.01% | 1767 |
|
|
2018
Q3 | $1.71M | Buy |
31,217
+2,934
| +10% | +$168K | 0.01% | 1331 |
|
|
2018
Q2 | $1.66M | Sell |
28,283
-46,117
| -62% | -$2.75M | 0.01% | 1356 |
|
|
2018
Q1 | $4.22M | Sell |
74,400
-6,966
| -9% | -$379K | 0.01% | 1117 |
|
|
2017
Q4 | $4.01M | Buy |
81,366
+9,546
| +13% | +$435K | 0.01% | 1161 |
|
|
2017
Q3 | $3.28M | Sell |
71,820
-1,914
| -3% | -$73.1K | 0.01% | 1312 |
|
|
2017
Q2 | $2.88M | Buy |
73,734
+6,894
| +10% | +$264K | 0.01% | 1356 |
|
|
2017
Q1 | $2.71M | Sell |
66,840
-8,366
| -11% | -$328K | 0.01% | 1424 |
|
|
2016
Q4 | $2.89M | Buy |
75,206
+867
| +1% | +$29.6K | 0.01% | 1403 |
|
|
2016
Q3 | $2.37M | Sell |
74,339
-3,214
| -4% | -$122K | 0.01% | 1507 |
|
|
2016
Q2 | $3.1M | Sell |
77,553
-3,932
| -5% | -$145K | 0.01% | 1277 |
|
|
2016
Q1 | $2.74M | Sell |
81,485
-15,651
| -16% | -$448K | 0.01% | 1357 |
|
|
2015
Q4 | $3.02M | Sell |
97,136
-21,027
| -18% | -$623K | 0.01% | 1323 |
|
|
2015
Q3 | $3.55M | Buy |
118,163
+1,488
| +1% | +$49.1K | 0.01% | 1217 |
|
|
2015
Q2 | $3.69M | Buy |
116,675
+30,592
| +36% | +$799K | 0.01% | 1322 |
|
|
2015
Q1 | $1.99M | Buy |
86,083
+18,633
| +28% | +$386K | ﹤0.01% | 1786 |
|
|
2014
Q4 | $1.32M | Buy |
67,450
+18,673
| +38% | +$321K | ﹤0.01% | 2042 |
|
|
2014
Q3 | $766K | Sell |
48,777
-162,805
| -77% | -$2.32M | ﹤0.01% | 2363 |
|
|
2014
Q2 | $2.6M | Buy |
211,582
+96,130
| +83% | +$1.15M | 0.01% | 1600 |
|
|
2014
Q1 | $1.59M | Sell |
115,452
-15,283
| -12% | -$220K | ﹤0.01% | 1941 |
|
|
2013
Q4 | $1.92M | Buy |
130,735
+110,765
| +555% | +$1.5M | 0.01% | 1825 |
|
|
2013
Q3 | $274K | Sell |
19,970
-1,001
| -5% | -$14.7K | ﹤0.01% | 2636 |
|
|
2013
Q2 | $300K | Buy |
+20,971
| New | +$295K | ﹤0.01% | 2616 |
|
Other funds holding AMN
VCM
VPM
Guggenheim Capital's AMN Position: Q1 2026 in Review
Guggenheim Capital sold out of AMN Healthcare (AMN) in Q1 2026, closing a stake of 23,810 shares — an estimated $375K sold.
Guggenheim Capital first reported a position in AMN in Q2 2013 and held it in 44 quarters. The position peaked at $4.22M in Q1 2018. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.
- Guggenheim Capital reported no remaining AMN Healthcare position as of Q1 2026 after selling out during the quarter.
- Guggenheim Capital sold 23,810 AMN Healthcare shares in Q1 2026, an estimated $375K.
- Guggenheim Capital first reported a position in AMN Healthcare in Q2 2013 and held it in 44 quarters.
- Guggenheim Capital's AMN Healthcare position peaked at $4.22M in Q1 2018.
- 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.